Estimate your Current Waste

Estimate the Value of Recoverable Neurotoxin Loss

Configure your protocol and usage to see potential savings.
# of Syringes Per 100 U VIAL 9
Cost per Neurotoxin Unit $5.00
Botox ~$6.50 · Xeomin ~$4.75 · Jeuveau ~$4.25 · Dysport ~$4.50 · Daxxify ~$7.00
# of Vials Per Month 100
—
Current
→
—
NavaClick
Cost Per Vial
Monthly Recoverable Yield Value
$0
Modeled vial utilization
—
NavaClick vs current
Net Per Vial
—
Current Waste
— U
NavaClick Loss
— U
Cost Breakdown Per Vial
Category
Current
NavaClick
Lost Drug Value
—
—
Consumables
—
—
Sharps Disposal
—
—
Total Per Vial
—
—
Net Savings
—
Cost Calculations Explained
  • Current Method Cost: Value of drug lost in the vial, needle hub, and syringe + cost of syringes + sharps disposal fees.
  • NavaClick Cost: Value of remaining drug waste + NavaClick kit cost ($10.00) + sharps disposal.
  • Total Savings: Current Method Cost minus NavaClick Total Cost.
Sources & Baselines
  • Vial residual: 0.075 mL (3 U), a model assumption informed by Niamtu (2014).
  • Per-syringe residual: Standard 1 mL: 0.050 mL (2 U), Foglietti et al. (2018). Fixed-needle insulin: 0.034 mL (1.36 U), Gultekin et al. (2026).
  • NavaClick: 0.066 mL mechanical-loss model baseline (2.64 U), based on internal testing TR 25-008 using the vial adapter plus 22G access needle. The displayed 97.4% is modeled utilization at 2.5 mL, distinct from the internal study utilization.
Model Assumptions
  • Model basis: 100 U in 2.5 mL (40 U/mL). Units are product-specific and are not interchangeable between toxin brands. Enter the acquisition cost appropriate to this modeled vial.
  • Waste formula: 0.075 mL vial residual + selected syringe count × per-syringe residual. No automatic dosing-variability penalty. Choose 1–19 syringes to represent your workflow; defaults are 3, 5, and 9. Disposal is $0.27 per syringe. Counts below full-vial capacity are partial-volume scenarios; unused vial contents are not modeled.
  • Scope: Estimated savings, not guaranteed results. Published residual benchmarks apply to specific tested devices; applying them across syringe counts and capacities is a modeled extrapolation. Access configuration and technique differ. This is not a head-to-head clinical study of NavaClick.